# Italy Drug Infusion System Market

> Italy Drug Infusion System Market Research Report: Size, Share, Trend Analysis By Product Type (Elastomeric Infusion System, Disposable Infusion System), By Applications (Oncology/Chemotherapy), By Mode of Administration (Intravenous), and By End Users (Hospitals) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 8.11%
- **2024:** $ 296.1 Million
- **2025:** $ 320.11 Million
- **2035:** $ 698.2 Million
- **Key Players:** Baxter International Inc (US), B. Braun Melsungen AG (DE), Medtronic plc (IE), Smiths Medical (US), Fresenius Kabi AG (DE), Terumo Corporation (JP), ICU Medical Inc (US), Halyard Health Inc (US)

**Report ID:** MRFR/Pharma/54779-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** February 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/italy-drug-infusion-system-market-56545

---

## Market Summary

## **Italy Drug Infusion System Market Overview**

As per MRFR analysis, the Italy Drug Infusion System Market Size was estimated at USD 324.38 Million in 2023. The Italy Drug Infusion System Market Industry is expected to grow from USD 340.62 Million in 2024 to USD 548.92 Million by 2035. The Italy Drug Infusion System Market CAGR (growth rate) is expected to be around 4.434% during the forecast period (2025 - 2035).

### **Key Italy Drug Infusion System Market Trends Highlighted**

The Italy Drug Infusion System Market is currently witnessing significant trends driven by the rising demand for advanced healthcare solutions and an increase in chronic disease prevalence. As the Italian population ages, there is a greater need for effective drug delivery systems that facilitate at-home and hospital-based care. The increased focus on patient-centered care has led to the development of user-friendly drug infusion systems that enhance patient compliance and comfort.

Moreover, the Italian healthcare system is increasingly investing in technological advancements, supporting the integration of smart infusion pumps equipped with monitoring systems to reduce medication errors. In Italy's drug infusion sector, there are opportunities to be pursued, particularly in the development of portable and wireless drug delivery systems that are designed to accommodate the increasing prevalence of ambulatory care.

The Italian government promotes innovation in the medical technology sector by encouraging partnerships between healthcare providers and manufacturers to develop customized solutions for patients. The COVID-19 pandemic has accelerated the growth of telemedicine, which has opened up a new opportunity for the development of drug infusion systems that can be remotely monitored. This has the potential to improve patient care and safety.

In recent years, there has been a significant emphasis on personalized medicine, necessitating drug infusion systems that are both adaptable and flexible. The global trend toward personalized healthcare is reflected in the trends in Italy, which are characterized by a transition to systems that can be tailored to the unique requirements and treatment protocols of individual patients.

Furthermore, the Italian commitment to environmental preservation is being reflected in the increasing importance of sustainability considerations as manufacturers seek environmentally favorable materials and processes for drug infusion system production. The landscape of the drug infusion system market in Italy is being influenced by all of these factors, which suggests that the sector is dynamic and dynamically evolving.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Italy Drug Infusion System Market Drivers**

### **Increasing Incidence of Chronic Diseases**

The rising incidence of chronic diseases such as diabetes, cancer, and cardiovascular disorders is a significant driver for the Italy Drug Infusion System Market Industry. According to a report by the Italian Ministry of Health, nearly 5 million people in Italy are living with diabetes, which is expected to increase by approximately 3% annually over the next decade.

This trend is supported by major health organizations, such as the Italian Diabetes Society, which indicates that diabetes-related complications necessitate continuous drug infusion systems for effective management. With the aging population and lifestyle changes, the demand for drug infusion systems is projected to escalate, thereby bolstering market growth.

### **Technological Advancements in Infusion Systems**

Innovations in drug infusion technologies play a pivotal role in enhancing patient care and expanding the Italy Drug Infusion System Market Industry. For instance, advancements in smart infusion pumps that offer features like dose error reduction and telemetry have been reported by major medical device manufacturers such as InfuSystem Holdings, which have introduced state-of-the-art infusion systems that not only improve efficiency but also reduce the risk of medication errors.

These innovations are crucial in hospitals and healthcare facilities across Italy, where there is a high emphasis on patient safety and quality of care.

### **Government Initiatives to Improve Healthcare Facilities**

Government policies aimed at enhancing healthcare infrastructure in Italy are also driving the growth of the Italy Drug Infusion System Market Industry. The Italian government has allocated significant funding towards upgrading hospital facilities and technology, with an investment of over 10 billion euros in the past two years, aimed specifically at expanding capacity and improving medical technology access.

This boost in healthcare spending is expected to lead to increased adoption of drug infusion systems, as healthcare providers are more likely to invest in advanced treatment options that facilitate better patient outcomes.

### **Rising Awareness of Home Healthcare Services**

There is a growing trend towards home healthcare services in Italy, which is significantly impacting the demand for portable drug infusion systems. Research shows that approximately 2.5 million people in Italy utilized home healthcare services in 2022, reflecting a 15% increase from the previous year, according to data from the Italian National Institute of Statistics.

This rising awareness is driven by the preference for comfort and convenience among patients, as well as recommendations from healthcare providers for chronic disease management at home. Major companies like Baxter International are expanding their product offerings to cater to this market segment, further facilitating growth in the drug infusion system sector.

## **Italy Drug Infusion System Market Segment Insights**

### **Drug Infusion System Market Product Type Insights**

The Italy [Drug Infusion System Market](../../../reports/drug-infusion-system-market-6207) is a diverse and evolving sector that focuses on the delivery of medications to patients through various methods, which primarily fall into different product types. Among these, the Elastomeric Infusion System stands out due to its ease of use, reliability, and ability to deliver precise dosages over extended periods.

This system harnesses the elasticity of materials to create a pump that administers a continuous flow of drugs, making it particularly suitable for outpatient care and chronic conditions where patients require ongoing medication without the complications of more invasive methods. As healthcare in Italy advocates for more patient-centered solutions, elastomeric systems gain importance for their efficiency in home-based care settings, reflecting the broader trends in the healthcare landscape favoring cost-effective and user-friendly treatments.

On the other hand, the Disposable Infusion System addresses the growing need for convenience and safety in drug delivery. These systems are designed for single-use, which reduces the risk of cross-contamination and infections, making them increasingly popular among healthcare providers focused on patient safety. In Italy, the emphasis on infection control and hygiene practices amplifies the significance of disposable options within the market.

Additionally, with advancements in technology, disposable infusion systems have become more sophisticated, providing healthcare professionals with features that allow for accurate dosage and enhanced patient compliance. Both product types cater to the evolving demands of the healthcare sector, showcasing a blend of innovative technology and strong adherence to safety regulations, which are pivotal in the dynamic Italian healthcare environment.

The segmentation of the Italy Drug Infusion System Market illustrates the area's potential for growth, with each product type contributing uniquely to the overall enhancement of therapeutic practices in medical settings.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Drug Infusion System Market Application Insights**

The Italy Drug Infusion System Market, particularly within the Application segment, showcases a vital focus on Oncology/Chemotherapy. This area has gained prominence due to the increasing incidence of cancer in Italy, making effective drug delivery systems essential for treatment. Drug infusion systems play a crucial role in administering chemotherapy, ensuring precise dosage, and enhancing patient comfort.

The growing adoption of these systems is also driven by advancements in technology, which have improved the accuracy and efficiency of drug delivery. Moreover, healthcare policies in Italy emphasize personalized treatment, further bolstering the demand for effective infusion systems in oncology. It is noteworthy that this segment has a significant influence on patient outcomes, as accurate and timely drug administration can substantially impact the effectiveness of cancer therapies.

As Italy's healthcare system evolves, the market for drug infusion systems in oncology is expected to continue evolving to meet clinical needs and improve overall patient care.

### **Drug Infusion System Market Mode of Administration Insights**

The Mode of Administration segment within the Italy Drug Infusion System Market plays a crucial role in delivering medications effectively to patients. Particularly, the intravenous method stands out due to its rapid onset action and ability to administer large volumes of fluids and medications efficiently. This method is widely preferred in hospital settings, especially for patients requiring critical care, surgeries, or those receiving chemotherapy.

As the Italian healthcare system increasingly prioritizes patient-centric approaches, the demand for intravenous delivery systems is expected to grow, driven by their effectiveness and precision in medication administration. Furthermore, advancements in technology, such as smart infusion pumps, enhance the safety and accuracy of intravenous therapy, making it an essential practice in Italian medical facilities.

With a significant emphasis on ensuring optimal patient outcomes and minimizing complications, the intravenous route continues to dominate the landscape of drug administration in Italy, reflecting broader trends in the healthcare industry that prioritize efficiency and safety. The growing needs of an aging population and the increased prevalence of chronic diseases further support the importance of this mode of administration in the evolving Italian healthcare environment.

### **Drug Infusion System Market End User Insights**

The End User segment of the Italy Drug Infusion System Market plays a crucial role, particularly within hospitals, which represent a significant portion of the market. Hospitals are essential as they are primary centers for patient care, where drug infusion systems are extensively utilized to deliver medications efficiently and accurately.

The growing focus on improving patient outcomes in Italy's healthcare system has driven a demand for advanced drug infusion technologies that enhance safety and effectiveness. Various trends, including the integration of smart technologies in infusion systems, are shaping the landscape, with hospitals seeking to reduce medication errors and optimize resource management.

Additionally, the increasing prevalence of chronic diseases in Italy necessitates effective drug administration, positioning hospitals as key players in adopting innovative infusion solutions. The constant need to adapt to new treatment protocols presents opportunities for the market to evolve and address the changing dynamics of healthcare delivery.

Collaborations between hospitals and technology providers are becoming more common as they aim to leverage Italy's robust healthcare infrastructure and enhance the overall efficiency of drug delivery systems. Thus, hospitals are not only pivotal for the present landscape of the Italy Drug Infusion System Market but also for future advancements in patient care methodologies.

## **Italy Drug Infusion System Market Key Players and Competitive Insights**

The Italy Drug Infusion System Market reflects a dynamic landscape where innovation, technological advancement, and competitive strategies play critical roles in shaping industry growth. With an increasing demand for efficient medication delivery solutions, especially due to the rising prevalence of chronic diseases and an aging population, the market has become an area of interest for key players.

Companies in this sector are focusing on expanding their product offerings and tapping into the latest technologies to enhance patient care and safety. As companies vie for market share, understanding competitive dynamics becomes essential for stakeholders to navigate through opportunities and challenges, ensuring sustained growth in this challenging environment.

In the context of the Italy Drug Infusion System Market, BD has established a strong presence, leveraging its expertise in the field of medical devices and technologies. The company is well-regarded for its high-quality infusion systems that are tailored to meet the specific requirements of healthcare facilities across Italy. Its focus on innovation and dedicated research and development efforts enable BD to introduce advanced products that enhance the overall efficiency and safety of drug administration.

With a commitment to patient care, BD's products often feature integrated safety mechanisms that mitigate risks associated with drug delivery, thereby establishing the company as a leader in this market segment. Additionally, BD has formed strategic alliances and partnerships in the region that bolster its market presence and foster growth opportunities, further enhancing its competitive position.

ICU Medical has also carved out a significant niche in the Italy Drug Infusion System Market, focusing on providing advanced solutions that support critical care and outpatient treatments. The company's product lineup includes sophisticated infusion systems and components that are renowned for their reliability and user-friendly designs, catering specifically to the demands of healthcare institutions.

ICU Medical's strong emphasis on safety features and integration capabilities allows for seamless adoption into existing healthcare workflows in Italy. The company's growth has been further supported by strategic mergers and acquisitions that have expanded its portfolio and market reach. These initiatives, combined with ongoing innovation, ensure that ICU Medical remains a competitive force in the industry, addressing the evolving needs of the Italian healthcare market while delivering high-value solutions to its customers.

### **Key Companies in the Italy Drug Infusion System Market Include**

- BD
- ICU Medical
- C.r. Bard
- [Medtronic](https://www.medtronic.com/en-us/healthcare-professionals/products/neurological/drug-infusion-systems.html#aq=%40pagetype%3D%22product-model%22&cq=%40products_group%3D%22Drug%20infusion%20systems%22%20OR%20%40ontology_isa%3D%22Drug%20infusion%20systems%22)
- Fresenius Kabi
- Zyno Medical
- Smiths Medical
- Moog Inc.
- Terumo Corporation
- Sorin Group
- Amsino International
- Halyard Health
- Baxter International
- B. Braun Melsungen AG

## **Italy Drug Infusion System Market Industry Developments**

The Italy Drug Infusion System Market has experienced several significant developments recently. Key players such as BD, ICU Medical, C.r. Bard, Medtronic, and Fresenius Kabi continue to innovate and expand their offerings, focusing on technological advancements to enhance patient safety and treatment efficacy. As of September 2023, BD announced the expansion of its Manufacturing facility in Italy to boost production capacity for advanced drug infusion devices, responding to the increasing demand in the healthcare sector.

In recent months, notable mergers and acquisitions have been in focus, although there have been no major public announcements of such activity in this sector for the companies mentioned. The demand for drug infusion systems has steadily grown, prompted by the rising prevalence of chronic diseases, with an estimated market valuation increase of around 8% in the last year.

Noteworthy trends include an ongoing shift toward smart infusion pumps and devices equipped with dosage error reduction systems. Regulatory frameworks in Italy have also seen updates to improve the operational standards of drug delivery systems aligning with European Union directives. The market dynamics are continually evolving, reflecting broader shifts in healthcare priorities and technological advancements.

## **Italy Drug Infusion System Market Segmentation Insights**

### **Drug Infusion System Market Product Type Outlook**

- Elastomeric Infusion System
- Disposable Infusion System

### **Drug Infusion System Market Application Outlook**

- Oncology/Chemotherapy

### **Drug Infusion System Market Mode of Administration Outlook**

- Intravenous

### **Drug Infusion System Market End User Outlook**

- Hospitals

## Market Drivers

### Growing Prevalence of Chronic Diseases

The drug infusion-system market is significantly influenced by the growing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders. As the population ages, the incidence of these conditions is expected to rise, leading to an increased demand for effective treatment options. Current statistics suggest that chronic diseases account for nearly 70% of all deaths in Italy, highlighting the urgent need for reliable drug delivery systems. Infusion therapy is often a critical component of treatment regimens for these diseases, necessitating the development of advanced drug infusion systems. This trend indicates a robust growth trajectory for the market, as healthcare providers seek to implement more effective management strategies for chronic conditions.

### Technological Integration in Healthcare

The integration of advanced technologies in healthcare is reshaping the drug infusion-system market. Innovations such as smart infusion pumps, remote monitoring, and data analytics are enhancing the efficiency and safety of drug delivery. These technologies allow for precise dosing, real-time monitoring, and improved patient compliance, which are essential for effective treatment outcomes. The market is witnessing a shift towards digital health solutions, with an estimated growth rate of 10% in the adoption of smart infusion devices over the next few years. This technological evolution not only improves patient care but also streamlines hospital operations, making it a pivotal driver for the drug infusion-system market.

### Focus on Cost-Effectiveness and Efficiency

In the Italian healthcare landscape, there is a growing emphasis on cost-effectiveness and efficiency in treatment delivery. The drug infusion-system market is responding to this demand by developing systems that minimize waste and optimize resource utilization. Healthcare providers are increasingly seeking solutions that offer both quality and affordability, as budget constraints become more pronounced. Recent analyses indicate that hospitals are looking to reduce operational costs by approximately 15% over the next few years, which is likely to influence purchasing decisions in the drug infusion-system market. This focus on cost-effectiveness may drive innovation, as manufacturers strive to create systems that meet both clinical and economic needs.

### Rising Demand for Home Healthcare Solutions

The drug infusion-system market is experiencing a notable increase in demand for home healthcare solutions. This trend is driven by an aging population and a growing preference for at-home treatments. As more patients seek to manage chronic conditions from the comfort of their homes, the need for efficient and reliable drug infusion systems becomes paramount. According to recent estimates, the home healthcare market is projected to grow at a CAGR of approximately 8% over the next five years. This shift not only enhances patient comfort but also reduces hospital readmission rates, thereby alleviating pressure on healthcare facilities. Consequently, manufacturers are focusing on developing user-friendly and portable infusion devices tailored for home use, which is likely to further propel the drug infusion-system market.

### Increased Investment in Healthcare Infrastructure

Italy's drug infusion-system market is benefiting from increased investment in healthcare infrastructure. The Italian government has allocated substantial funds to modernize healthcare facilities, which includes upgrading medical equipment and technology. This investment is crucial as it aims to improve patient outcomes and streamline healthcare delivery. Reports indicate that healthcare spending in Italy is expected to rise by approximately 5% annually, with a significant portion directed towards advanced medical technologies. As hospitals and clinics adopt state-of-the-art drug infusion systems, the market is likely to expand, driven by the need for more efficient and effective treatment options. This trend underscores the importance of innovation in the drug infusion-system market, as healthcare providers seek to enhance their service offerings.

## Future Outlook

The [Drug Infusion System Market](https://www.marketresearchfuture.com/reports/drug-infusion-system-market-6207) in Italy is poised for growth at 8.11% CAGR from 2025 to 2035, driven by technological advancements and increasing healthcare demands.

**New opportunities:**

- Development of smart infusion pumps with IoT connectivity
- Expansion of home healthcare infusion services
- Integration of AI for personalized medication delivery

By 2035, the market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Product Type: Elastomeric Infusion System (Largest) vs. Disposable Infusion System (Fastest-Growing)

In the Italy drug infusion-system market, the product type segment is diverse, featuring various systems tailored for distinct therapeutic applications. The elastomeric infusion system holds the largest share, thanks to its effectiveness in delivering medications over an extended period. This is closely followed by disposable infusion systems, which have gained popularity due to their convenience and cost-effectiveness. Other products such as syringe infusion systems, peristaltic pumps, and PCA pumps collectively contribute to a significant portion of the market, catering to specialized healthcare needs.

Analyzing growth trends, the disposable infusion system has emerged as the fastest-growing product due to rising patient demand for safety and hygiene in healthcare settings. A notable shift towards outpatient procedures and home healthcare also drives this growth, augmenting the adoption of user-friendly infusion systems. The insulin pump segment shows a steady increase as the prevalence of diabetes rises, thus becoming a crucial player in the infusion system landscape.

Elastomeric Infusion System: Dominant vs. Disposable Infusion System: Emerging

The elastomeric infusion system is a dominant player in the Italy drug infusion-system market, primarily known for its simplicity and ease of use. It offers a reliable method for continuous drug delivery without the need for electronic devices, making it highly preferred in various clinical settings. On the other hand, the disposable infusion system is emerging rapidly, driven by healthcare's shift toward safety and convenience. This system minimizes the risk of infections and reduces the burden of sterilization processes, appealing to healthcare providers and patients alike. As consumer preferences evolve towards more hygienic solutions, the disposable infusion system's market position is strengthening, making it a significant competitor to established products.

### By Application: Oncology/Chemotherapy (Largest) vs. Diabetes (Fastest-Growing)

The Italy drug infusion-system market displays distinct market share distribution among various applications. Oncology/Chemotherapy holds the largest share, reflecting the increasing prevalence of cancer treatments and the high dependency on drug infusion systems for effective delivery. Following closely are Diabetes and Analgesia segments, which illustrate significant demand driven by the rising incidence of diabetes and chronic pain management, respectively, highlighting the diversifying needs across the healthcare landscape.

In terms of growth trends, the market is witnessing a surge in the Diabetes segment, identified as the fastest-growing area fueled by technological advancements in infusion systems and the growing population of diabetics. The growing emphasis on personalized medicine and innovative drug delivery solutions also propels other segments such as Pediatrics and Hematology, as healthcare providers increasingly prioritize tailored treatments to enhance patient outcomes and satisfaction.

Oncology/Chemotherapy (Dominant) vs. Diabetes (Emerging)

The Oncology/Chemotherapy segment is established as the dominant force in the Italy drug infusion-system market, characterized by a robust demand for precision in delivering chemotherapeutic agents, thereby ensuring efficacy and safety. This segment's strong presence is attributed to high investment in cancer treatment facilities and the availability of advanced infusion systems. In contrast, the Diabetes segment is emerging rapidly due to technological progress and a heightened focus on chronic disease management. The proliferation of insulin delivery systems, including smart pumps and automated devices, is reshaping the landscape for diabetes care, potentially leading to improved patient adherence and managing blood glucose levels efficiently. Both segments illustrate a dynamic interplay of innovation and patient-centered care.

### By Mode of administration: Intravenous (Largest) vs. Subcutaneous (Fastest-Growing)

In the Italy drug infusion-system market, the mode of administration segment showcases a diverse array of options. Intravenous administration dominates, holding the largest market share due to its rapid delivery and efficiency in treating critical patients. Subcutaneous administration is gaining traction as it offers ease of use and comfort for patients, which contributes to a noticeable share in the market. Other methods like arterial and epidural also play significant roles, albeit with lesser shares.

Growth trends within this segment are driven by advancements in technology and an increasing focus on patient-centric approaches. Subcutaneous infusion systems are particularly emerging as the fastest-growing option, largely attributed to an increase in chronic diseases requiring long-term infusions. The shift towards home healthcare settings further accelerates this growth, making it more accessible and appealing for patients who prefer minimal hospital visits for their treatments.

Intravenous (Dominant) vs. Subcutaneous (Emerging)

Intravenous administration remains the dominant mode in the Italy drug infusion-system market, primarily due to its effectiveness in delivering medications directly into the bloodstream, which is crucial for emergency care and various chronic conditions. Its established protocols and extensive use in hospitals solidify its position. In contrast, subcutaneous administration is emerging as a preferred alternative, gaining popularity for its convenience and comfort for outpatient care. This method allows self-administration, which is particularly advantageous for patients with chronic illnesses needing consistent medication. With technological innovations enhancing the safety and efficiency of subcutaneous delivery systems, this segment is poised for significant growth.

### By End-user: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

The Italy drug infusion-system market exhibits a diverse distribution across various end-user segments, with hospitals holding the largest market share. This dominance is attributed to their extensive reliance on infusion systems for a wide range of treatments and patient care protocols. In contrast, ambulatory surgical centers are emerging as a significant player, contributing to a burgeoning segment characterized by increased outpatient procedures.

Growth trends indicate a robust expansion in the adoption of drug infusion systems, particularly within ambulatory surgical centers, driven by advancements in technology and a shift towards less invasive surgical options. The increasing prevalence of chronic diseases and the need for effective management solutions further catalyze this growth. As healthcare organizations seek to enhance patient outcomes, the demand for efficient infusion systems continues to rise.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals have established themselves as the dominant end-user segment in the Italy drug infusion-system market, largely due to their extensive service offerings and the critical role of infusion technologies in patient treatment. They utilize a variety of infusion systems to cater to diverse patient needs, from cancer therapies to pediatric care. Conversely, ambulatory surgical centers are rapidly emerging as a key segment, benefitting from growing trends in outpatient care, which eliminate the need for lengthy hospital stays. These centers emphasize efficiency and patient convenience, adopting innovative infusion solutions to enhance their operational capabilities and respond to the increasing demand for outpatient services.

## Competitive Benchmarking

The drug infusion-system market exhibits a dynamic competitive landscape characterized by rapid technological advancements and a growing emphasis on patient-centric solutions. Key players such as Baxter International Inc (US), B. Braun Melsungen AG (DE), and Medtronic plc (IE) are at the forefront, each adopting distinct strategies to enhance their market presence. Baxter International Inc (US) focuses on innovation through the development of advanced infusion systems that integrate digital health technologies, thereby improving patient outcomes and operational efficiency. Meanwhile, B. Braun Melsungen AG (DE) emphasizes regional expansion and strategic partnerships, which appear to bolster its distribution capabilities and market penetration. Medtronic plc (IE) is also notable for its commitment to digital transformation, leveraging data analytics to optimize infusion therapies and enhance user experience. Collectively, these strategies contribute to a competitive environment that is increasingly driven by technological innovation and strategic collaborations.
In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and enhance supply chain efficiency. This approach not only mitigates risks associated with The drug infusion-system market demands. The competitive structure of the market is moderately fragmented, with several key players exerting influence over various segments. The collective actions of these companies shape a landscape where innovation and operational excellence are paramount.
In October 2025, Fresenius Kabi AG (DE) announced the launch of a new line of smart infusion pumps designed to enhance medication safety and streamline workflows in clinical settings. This strategic move underscores the company's commitment to addressing the growing demand for advanced infusion technologies that prioritize patient safety. The introduction of these smart devices is likely to strengthen Fresenius Kabi's competitive position by appealing to healthcare providers seeking to improve care delivery.
In September 2025, ICU Medical Inc (US) completed the acquisition of a leading infusion technology firm, which is expected to expand its product portfolio and enhance its market share in Italy. This acquisition reflects a broader trend of consolidation within the industry, as companies seek to leverage synergies and accelerate innovation. The integration of new technologies and expertise from the acquired firm may provide ICU Medical with a competitive edge in delivering comprehensive infusion solutions.
In August 2025, Terumo Corporation (JP) launched a new digital platform aimed at optimizing infusion therapy management. This platform integrates real-time data analytics and remote monitoring capabilities, which could significantly enhance patient care and operational efficiency. By investing in digital solutions, Terumo appears to be positioning itself as a leader in the digital transformation of infusion systems, aligning with current market trends that favor technology-driven healthcare solutions.
As of November 2025, the competitive trends in the drug infusion-system market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI). Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing product offerings. The shift from price-based competition to a focus on technological advancement and supply chain reliability is evident, suggesting that future competitive differentiation will hinge on the ability to innovate and deliver superior patient outcomes.

## Recent News & Developments

The Italy Drug Infusion System Market has experienced several significant developments recently. Key players such as BD, ICU Medical, C.r. Bard, Medtronic, and Fresenius Kabi continue to innovate and expand their offerings, focusing on technological advancements to enhance patient safety and treatment efficacy. As of September 2023, BD announced the expansion of its Manufacturing facility in Italy to boost production capacity for advanced drug infusion devices, responding to the increasing demand in the healthcare sector.

In recent months, notable mergers and acquisitions have been in focus, although there have been no major public announcements of such activity in this sector for the companies mentioned. The demand for drug infusion systems has steadily grown, prompted by the rising prevalence of chronic diseases, with an estimated market valuation increase of around 8% in the last year.

Noteworthy trends include an ongoing shift toward smart infusion pumps and devices equipped with dosage error reduction systems. Regulatory frameworks in Italy have also seen updates to improve the operational standards of drug delivery systems aligning with European Union directives. The market dynamics are continually evolving, reflecting broader shifts in healthcare priorities and technological advancements.

## Report Scope

| MARKET SIZE 2024 | 296.1(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 320.11(USD Million) |
| MARKET SIZE 2035 | 698.2(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.11% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Baxter International Inc (US), B. Braun Melsungen AG (DE), Medtronic plc (IE), Smiths Medical (US), Fresenius Kabi AG (DE), Terumo Corporation (JP), ICU Medical Inc (US), Halyard Health Inc (US) |
| Segments Covered | Product Type, Application, Mode of administration, End-user |
| Key Market Opportunities | Integration of smart technology in drug infusion systems enhances patient monitoring and treatment efficiency. |
| Key Market Dynamics | Rising demand for advanced drug infusion systems driven by regulatory changes and technological innovations in healthcare. |
| Countries Covered | Italy |

## Frequently Asked Questions

**Q: What is the projected market valuation for the Italy drug infusion-system market in 2035?**
A: The projected market valuation for the Italy drug infusion-system market in 2035 is $698.2 Million.

**Q: What was the overall market valuation in 2024?**
A: The overall market valuation in 2024 was $296.1 Million.

**Q: What is the expected CAGR for the Italy drug infusion-system market during the forecast period 2025 - 2035?**
A: The expected CAGR for the Italy drug infusion-system market during the forecast period 2025 - 2035 is 8.11%.

**Q: Which product type segment had the highest valuation in 2024?**
A: The disposable infusion system segment had the highest valuation in 2024, ranging from $50.0 Million to $120.0 Million.

**Q: What are the key applications driving the Italy drug infusion-system market?**
A: Key applications include oncology/chemotherapy, diabetes, and analgesia, with oncology/chemotherapy valued at $59.5 Million to $139.5 Million in 2024.

**Q: Which mode of administration is expected to dominate the market?**
A: Intravenous administration is expected to dominate the market, with a valuation range of $118.46 Million to $276.12 Million in 2024.

**Q: What is the market valuation range for the patient-controlled analgesia (PCA) pump segment?**
A: The market valuation range for the patient-controlled analgesia (PCA) pump segment is $15.0 Million to $40.0 Million.

**Q: Which end-user segment had the highest valuation in 2024?**
A: The hospitals segment had the highest valuation in 2024, ranging from $118.46 Million to $276.12 Million.

**Q: What is the valuation range for the insulin pump segment in 2024?**
A: The valuation range for the insulin pump segment in 2024 is $10.0 Million to $30.0 Million.

**Q: Who are the key players in the Italy drug infusion-system market?**
A: Key players in the market include Baxter International Inc, B. Braun Melsungen AG, Medtronic plc, and Fresenius Kabi AG.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/italy-drug-infusion-system-market-56545*